Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets

Cytometry

Volumn 49, Issue 3, 2002, Pages 119-133

  Watala, Cezary ^a   Waczulikova, Iveta ^b   Wieclawska, Boguslawa ^a   Rozalski, Marcin ^a   Gresner, Peter ^b   Gwoździński, Krzysztof ^c   Mateasik, Anton ^d   Śikurova, Libuśa ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Faculty of Natural Sciences   (Slovakia)

^c UNIVERSITY OF LODZ   (Poland)

^d INTERNATIONAL LASER CENTER   (Slovakia)

Author keywords

Annexin V; Blood platelet activation; Flow cytometry; Merocyanine 540 (MC540); Platelet procoagulant activity

Indexed keywords

COLLAGEN; EGTAZIC ACID; LIPOCORTIN 5; MEMBRANE PHOSPHOLIPID; MEROCYANINE; PHOSPHATIDYLSERINE; PROCOAGULANT; THAPSIGARGIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR; FLUORESCENT DYE; LIPOSOME; MEROCYANINE DYE; PLATELET PROCOAGULANT FACTOR; PROTEIN; PYRIMIDINONE DERIVATIVE; THROMBIN RECEPTOR; VANADIC ACID;

ARTICLE; BILAYER MEMBRANE; FLOW CYTOMETRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; ADULT; CELL MEMBRANE; DOSE RESPONSE; DRUG EFFECT; ELECTRON SPIN RESONANCE; HUMAN; METABOLISM; SOLUBILITY;

ADULT; ANNEXIN A5; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; CELL MEMBRANE; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON SPIN RESONANCE SPECTROSCOPY; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; LIPOSOMES; PHOSPHATIDYLSERINES; PLATELET ACTIVATION; PROTEINS; PYRIMIDINONES; RECEPTORS, THROMBIN; SOLUBILITY; VANADATES;

EID: 0036835719     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.10152     Document Type: Article

References (43)

1. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990;76:1-16.
2. Gilbert GE, Drinkwater D. Specific membrane binding of factor VIII is mediated by O-phospho-L-serine, a moiety of phosphatidylserine. Biochemistry 1993;32:9577-9585.
3. Comfurius P, Smeets EF, Willems GM, Bevers EM, Zwaal RF. Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar headgroup of phosphatidylserine. Biochemistry 1994;33:10319-10324.
4. Devaux PF. Static and dynamic lipid asymmetry in cell membranes. Biochemistry 1991;30:1163-1173.
5. Schroit AJ, Zwaal RF. Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta 1991;1071:313-329.
6. Dachary-Prigent J, Pasquet JM, Freyssinet JM, Nurden AT. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors. Biochemistry 1995;34:11625-11634.
7. Martinez MC, Martin S, Toti F, Fressinaud E, Dachary-Prigent J, Meyer D, Freyssinet JM. Significance of capacitative Ca2+ entry in the regulation of phosphatidylserine expression at the surface of stimulated cells. Biochemistry 1999;38:10092-10098.
8. Ripova D, Strunecka A, Nemcova V, Farska I. Phospholipids and calcium alterations in platelets of schizophrenic patients. Physiol Res 1997;46:59-68.
9. Stillwell W, Wassall SR, Dumaual AC, Ehringer WD, Browning CW, Jenski LJ. Use of merocyanine (MC540) in quantifying lipid domains and packing in phospholipid vesicles and tumor cells. Biochim Biophys Acta 1993;1146:136-144.
10. Langner M, Hui SW. Merocyanine 540 as a fluorescence indicator for molecular packing stress at the onset of lamellar-hexagonal transition of phosphatidylethanolamine bilayers. Biochim Biophys Acta 1999; 1415:323-330.
11. Pasquet JM, Dachary-Prigent J, Nurden AT. Comparison between the loss of platelet membrane asymmetry, microvesiculation and the tyrosine phosphorylation of proteins. Prostaglandins Leukot Essent Fatty Acids 1997;57:451-453.
12. Dachary-Prigent J, Pasquet JM, Fressinaud E, Toti F, Freyssinet JM, Nurden AT. Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: a study using physiologic agonists and local anaesthetics. Br J Haematol 1997;99:959-967.
13. Thiagarajan P, Tait JF. Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem 1990; 265:17420-17423.
14. Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 1989;264:7944-7949.
15. Huber R, Schneider M, Mayr I, Romisch J, Paques EP. The calcium binding sites in human annexin V by crystal structure analysis at 2.0 A resolution. Implications for membrane binding and calcium channel activity. FEBS Lett 1990;275:15-21.
16. Vossen RC, Dam-Mieras MC, Hornstra G, Zwaal RF. Continuous monitoring of lipid peroxidation by measuring conjugated diene formation in an aqueous liposome suspension. Lipids 1993;28:857-861.
17. Disalvo EA, Campos AM, Abuin E, Lissi EA. Surface changes induced by osmotic shrinkage on large unilamellar vesicles. Chem Phys Lipids 1996;84:35-45.
18. Watala C, Golanski J, Bonder MA, Pietrucha T, Gwozdzinski K. Membrane lipid fluidity of blood platelets: a common denominator underlying the opposite actions of various agents affecting platelet activation in whole blood. Platelets 1998;9:315-327.
19. Watala C, Bonder M, Golanski J, Koziolkiewicz W, Walkowiak B, Cierniewski CS. Release of calcium and P-selectin from intraplatelet granules is hampered by procaine. Thromb Res 1999;94:1-11.
20. Watala C, Golanski J, Wieclawska B, Bonder M. Use of flow cytometry to differentiate between activation and reactivity of blood platelets. Med Sci Mon 1999;5:155-162.
21. Bode AP, Hickerson DH. Characterization and quantitation by flow cytometry of membranous microparticles formed during activation of platelet suspensions with ionophore or thrombin. Platelets 2000;11: 259-271.
22. Jenssen HL, Redmann K, Mix E. Flow cytometric estimation of transmembrane potential of macrophages: a comparison with microelectrode measurements. Cytometry 1986;7:339-346.
23. Petit PX, O'Connor JE, Grunwald D, Brown SC. Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications. Eur J Biochem 1990;194:389-397.
24. Watala C, Gwozdzinski K, Pluskota E, Dzieciatkowska E, Cierniewski CS. Microenvironmental changes in platelet membranes induced by the interaction of fibrinogen-derived peptide ligands with platelet integrins. Eur J Biochem 1996;235:281-288.
25. Galla HJ, Luisetti J. Lateral and transversal diffusion and phase transitions in erythrocyte membranes. An excimer fluorescence study. Biochim Biophys Acta 1980;596:108-117.
26. Zar J. Biostatistical analysis. Upper Saddle River, NJ: Prentice-Hall; 1999. 663 p.
27. Armitage P, Berry G. Statistical methods in medical research. London: Blackwell; 1994.
28. Dragsten PR, Webb WW. Mechanism of the membrane potential sensitivity of the fluorescent membrane probe merocyanine 540. Biochemistry 1978;17:5228-5240.
29. Loew LM, Bonneville GW, Surow J. Charge shift optical probes of membrane potential theory. Biochemistry 1978;17:4065-4071.
30. Waggoner AS, Grinvald A. Mechanisms of rapid optical changes of potential sensitive dyes. Ann N Y Acad Sci 1977;303:217-241.
31. Bernik DL, Disalvo EA. Gel state surface properties of phosphatidylcholine liposomes as measured with merocyanine 540. Biochim Biophys Acta 1993;1146:169-177.
32. Lelkes PI, Miller IR. Perturbations of membrane structure by optical probes: I. Location and structural sensitivity of merocyanine 540 bound to phospholipid membranes. J Membr Biol 1980;52:1-15.
33. Lagerberg JW, Kallen KJ, Haest CW, VanSteveninck J, Dubbelman TM. Factors affecting the amount and the mode of merocyanine 540 binding to the membrane of human erythrocytes. A comparison with the binding to leukemia cells. Biochim Biophys Acta 1995;1235:428-436.
34. Williamson P, Schlegel R. Maintenance of phospholipid asymmetry and its role in erythrocyte pathology. Prog Clin Biol Res 1984;159: 123-136.
35. Williamson P, Algarin L, Bateman J, Choe HR, Schlegel RA. Phospholipid asymmetry in human erythrocyte ghosts. J Cell Physiol 1985; 123:209-214.
36. Williamson P, Mattocks K, Schlegel RA. Merocyanine 540, a fluorescent probe sensitive to lipid packing. Biochim Biophys Acta 1983; 732:387-393.
37. Lagerberg JW, Uberriegler KP, Krammer B, VanSteveninck J, Dubbelman TM. Plasma membrane properties involved in the photodynamic efficacy of merocyanine 540 and tetrasulfonated aluminum phthalocyanine. Photochem Photobiol 2000;71:341-346.
38. Pipili E. Platelet membrane potential: simultaneous measurement of diSC3(5) fluorescence and optical density. Thromb Haemost 1985; 54:645-649.
39. MacIntyre DE, Rink TJ. The role of platelet membrane potential in the initiation of platelet aggregation. Thromb Haemost 1982;47:22-26.
40. Maruyama Y. A patch-clamp study of mammalian platelets and their voltage-gated potassium current. J Physiol 1987;391:467-485.
41. Gennis RB. Interactions of small molecules with membranes: partitioning, permeability and electrical effects. In: Cantor CR, editor. Biomembranes: molecular structure and function. New York: Springer Verlag; 1989. p 235-269.
42. Andree HA, Stuart MC, Hermens WT, Reutelingsperger CP, Hemker HC, Frederik PM, Willems GM. Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem 1992;267:17907-17912.
43. Sikurova L, Frankova R, Vavrekova A, Cunderlikova B. Effect of fluorescent agent MC 540 on phospholipid bilayer structure. J Fluorescence 1997;7:165-167.